LifeStance director receives RSU and PSU share awards

LifeStance Health Group director Kenneth A. Burdick reported compensation-related stock movements on March 9, 2026.

Rhea-AI Filing Summary

LifeStance Health Group director Kenneth A. Burdick reported compensation-related stock movements on March 9, 2026. He acquired common stock through vested restricted stock units and performance-based restricted stock units, with two grant or award acquisitions totaling 740,504 shares at a stated price of $0.00 per share.

To cover tax withholding obligations on these RSUs and PSUs, the issuer withheld 327,209 shares at $6.91 per share in three separate dispositions, which the footnotes clarify were not open-market sales. Following these transactions, Burdick directly held 3,425,315 shares, with an additional 46,511 shares held indirectly through Burdick Family LLC.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider Burdick Kenneth A

Role Director

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	35,816	$6.91	$247K
Grant/Award	Common Stock	33,544	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	13,201	$6.91	$91K
Grant/Award	Common Stock	706,960	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	278,192	$6.91	$1.92M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 3,425,315 shares (Direct); Common Stock — 46,511 shares (Indirect, By Burdick Family LLC)

Footnotes (5)

1. F1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
2. F2. Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 6, 2025, which vested on March 9, 2026.
3. F3. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.
4. F4. Represents PSUs previously granted to the Reporting Person on February 27, 2025, which vested on March 9, 2026.
5. F5. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did LFST director Kenneth Burdick report on March 9, 2026?

Kenneth A. Burdick reported RSU and PSU-related stock movements on March 9, 2026, including share awards and tax-withholding dispositions. These entries reflect equity compensation vesting rather than open-market buying or selling activity in LifeStance Health Group common stock.

How many LifeStance (LFST) shares were withheld for Kenneth Burdick’s taxes?

A total of 327,209 LifeStance shares were withheld at $6.91 per share to satisfy tax obligations. Footnotes state these tax-withholding dispositions reduced the net shares issued upon RSU and PSU settlement and did not involve any open-market sales.

What stock awards did Kenneth Burdick receive from LifeStance (LFST)?

Burdick reported two grant or award acquisitions of common stock tied to RSU and PSU vesting, totaling 740,504 shares at a stated price of $0.00 per share. These reflect equity compensation that increased his direct ownership position in LifeStance Health Group.

Did Kenneth Burdick sell LifeStance (LFST) shares on the open market?

The filing indicates no open-market sales. Shares labeled as tax-withholding dispositions were withheld by the issuer at $6.91 per share to cover RSU and PSU tax obligations, and footnotes explicitly state these do not constitute any open-market sale transactions.

How many LifeStance (LFST) shares does Kenneth Burdick hold after these transactions?

After the reported transactions, Burdick held 3,425,315 LifeStance shares directly. The filing also shows an additional 46,511 shares held indirectly through Burdick Family LLC, giving investors a clearer view of his total reported equity exposure in the company.

What type of equity awards vested for LifeStance (LFST) director Kenneth Burdick?

The filing describes vested restricted stock units (RSUs) and performance-based restricted stock units (PSUs). Footnotes note PSUs granted on March 6, 2025 and February 27, 2025 that vested on March 9, 2026, triggering share issuance and related tax-withholding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 07:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burdick Kenneth A

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE AZ 85251

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		F(1)		35,816	D	$6.91	2,976,204	D
Common Stock	03/09/2026		A		33,544(2)	A	$0.00	3,009,748	D
Common Stock	03/09/2026		F(3)		13,201	D	$6.91	2,996,547	D
Common Stock	03/09/2026		A		706,960(4)	A	$0.00	3,703,507	D
Common Stock	03/09/2026		F(5)		278,192	D	$6.91	3,425,315	D
Common Stock								46,511	I	By Burdick Family LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

2. Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 6, 2025, which vested on March 9, 2026.

3. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.

4. Represents PSUs previously granted to the Reporting Person on February 27, 2025, which vested on March 9, 2026.

5. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.

	By: /s/ Ryan Pardo, Attorney-in-Fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.